stockrowCigna Group
CI Healthcare Healthcare Plans
Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024.
- Revenue
- +5.64%
- EPS
- −21.6%
- Free cash flow
- −18.1%
- Total debt
- −8.51%
Quarter to September 2026, against a year earlier
Follow CI
Alert me
Cigna Group (CI) Return on equity
Cigna Group's return on equity over the twelve months to 30 September 2026 was 14.0%, down 0.4 percentage points from fiscal 2025 (14.3%). Over the past ten years it has ranged from 7.85% (fiscal 2024) to 18.3% (fiscal 2015); the current reading is higher than 55% of that period. That is in line with the Healthcare Plans industry median of 13.6% and above the Healthcare sector median of −26.0%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 14.3% | 6.48 |
| FY2024 | 7.85% | (3.51) |
| FY2023 | 11.4% | (3.24) |
| FY2022 | 14.6% | 3.58 |
| FY2021 | 11.0% | (6.66) |
| FY2020 | 17.7% | 5.86 |
| FY2019 | 11.8% | 2.19 |
| FY2018 | 9.63% | (6.68) |
| FY2017 | 16.3% | 1.82 |
| FY2016 | 14.5% | (3.85) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| OSCR Oscar Health, Inc. compare | 52.6% |
| PGNY Progyny, Inc. compare | 18.7% |
| UNH UnitedHealth Group Incorporated compare | 15.4% |
| CVS CVS Health Corporation compare | 14.4% |
| CI Cigna Group | 14.0% |
| ELV Elevance Health, Inc. compare | 11.6% |
| CNC Centene Corporation compare | 6.74% |
| HUM Humana Inc. compare | 6.65% |
| MOH Molina Healthcare, Inc compare | −1.15% |
| Healthcare Plans industry median | 13.6% |
| Healthcare sector median | −26.0% |
| Market median | 1.01% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on CI
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement